SCHEMBL21085189

SCHEMBL21085189

O=C(Nc1ccc(-c2coc3ncnc([AsH2])c23)cc1)Nc1cc(C(F)(F)F)ccc1F

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEK Q02763 10/20 0.80
FLT1 P17948 9/20 0.80
RIPK1 Q13546 8/20 0.80
CSF1R P07333 3/20 0.80
FLT4 P35916 3/20 0.80
GSK3A P49840 2/20 0.80
GSK3B P49841 2/20 0.80
SRC P12931 2/20 0.80
EGFR P00533 1/20 0.80
PDGFRB P09619 1/20 0.80
PDGFRA P16234 1/20 0.80
CDK2 P24941 1/20 0.80
AKT3 Q9Y243 1/20 0.80
KDR P35968 9/20 0.61
EPHB4 P54760 3/20 0.61
KIT P10721 4/20 0.59
FLT3 P36888 3/20 0.59
AURKA O14965 2/20 0.59
ABL1 P00519 2/20 0.59
LCK P06239 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gw770249X SCHEMBL30957039 0.89 TEK (1.00) TEKFLT1RIPK1CSF1RFLT4
Gw770249X SCHEMBL5652411 0.89 TEK (1.00) TEKFLT1RIPK1CSF1RFLT4
Gw770249X SCHEMBL29638046 0.89 TEK (1.00) TEKFLT1RIPK1CSF1RFLT4
SCHEMBL25008891 0.82 FLT1 (0.87) TEKFLT1RIPK1CSF1RFLT4
SCHEMBL3524617 0.78 TEK (0.75) TEKFLT1RIPK1CSF1RFLT4
SCHEMBL13708284 0.76 KDR (0.80) TEKFLT1RIPK1CSF1RFLT4
SCHEMBL3113394 0.74 KDR (1.00) TEKFLT1RIPK1CSF1RFLT4
SCHEMBL546436 0.74 KIT (1.00) TEKFLT1RIPK1CSF1RFLT4
SCHEMBL30055372 0.74 KIT (1.00) TEKFLT1RIPK1CSF1RFLT4
SCHEMBL24710786 0.74 FLT1 (0.71) TEKFLT1RIPK1CSF1RFLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12053454-B2 Compositions for cryopreservation and methods of use thereof EVERGREEN BIOSCIENCES (US) 2024-08-06 US disclosed
US-20190201381-A1 COMPOSITIONS FOR CRYOPRESERVATION AND METHODS OF USE THEREOF EVERGREEN BIOSCIENCES (US) 2019-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12053454-B2 Compositions for cryopreservation and methods of use thereof BAK1, BAX, BAD TEK 4326/4885FLT1 4124/4885RIPK1 12/4885
US-20190201381-A1 COMPOSITIONS FOR CRYOPRESERVATION AND METHODS OF USE THEREOF BAX, BAK1, CASP3 TEK 2662/4885FLT1 3859/4885RIPK1 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.